Literature DB >> 25936799

Humoral Immunity in the Gut Selectively Targets Phenotypically Virulent Attaching-and-Effacing Bacteria for Intraluminal Elimination.

Nobuhiko Kamada1, Kei Sakamoto2, Sang-Uk Seo2, Melody Y Zeng2, Yun-Gi Kim2, Marilia Cascalho3, Bruce A Vallance4, José L Puente5, Gabriel Núñez6.   

Abstract

Virulence factors expressed by enteric bacteria are pivotal for pathogen colonization and induction of intestinal disease, but the mechanisms by which host immunity regulates pathogen virulence are largely unknown. Here we show that specific antibody responses are required for downregulation of virulence gene expression in Citrobacter rodentium, an enteric pathogen that models human infections with attaching-and-effacing bacteria. In the absence of antibodies against the pathogen, phenotypically virulent C. rodentium, accumulated and infected the epithelium and subsequently invaded the lamina propia, causing host lethality. IgG induced after infection recognized virulence factors and bound virulent bacteria within the intestinal lumen, leading to their engulfment by neutrophils, while phenotypically avirulent pathogens remained in the intestinal lumen and were eventually outcompeted by the microbiota. Thus, the interplay of the innate and adaptive immune system selectively targets virulent C. rodentium in the intestinal lumen to promote pathogen eradication and host survival.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25936799      PMCID: PMC4433422          DOI: 10.1016/j.chom.2015.04.001

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  34 in total

1.  The antiapoptotic protein Mcl-1 is essential for the survival of neutrophils but not macrophages.

Authors:  Ivan Dzhagalov; Ashley St John; You-Wen He
Journal:  Blood       Date:  2006-10-24       Impact factor: 22.113

Review 2.  Pathogen subversion of cell-intrinsic innate immunity.

Authors:  Craig R Roy; Edward S Mocarski
Journal:  Nat Immunol       Date:  2007-11       Impact factor: 25.606

3.  Bicarbonate-mediated transcriptional activation of divergent operons by the virulence regulatory protein, RegA, from Citrobacter rodentium.

Authors:  Ji Yang; Emily Hart; Marija Tauschek; G Dean Price; Elizabeth L Hartland; Richard A Strugnell; Roy M Robins-Browne
Journal:  Mol Microbiol       Date:  2008-02-19       Impact factor: 3.501

4.  Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa.

Authors:  Kirk S B Bergstrom; Vanessa Kissoon-Singh; Deanna L Gibson; Caixia Ma; Marinieve Montero; Ho Pan Sham; Natasha Ryz; Tina Huang; Anna Velcich; B Brett Finlay; Kris Chadee; Bruce A Vallance
Journal:  PLoS Pathog       Date:  2010-05-13       Impact factor: 6.823

5.  Flagellin-dependent and -independent inflammatory responses following infection by enteropathogenic Escherichia coli and Citrobacter rodentium.

Authors:  Mohammed A Khan; Saeid Bouzari; Caixia Ma; Carrie M Rosenberger; Kirk S B Bergstrom; Deanna L Gibson; Theodore S Steiner; Bruce A Vallance
Journal:  Infect Immun       Date:  2008-01-28       Impact factor: 3.441

6.  Regulated virulence controls the ability of a pathogen to compete with the gut microbiota.

Authors:  Nobuhiko Kamada; Yun-Gi Kim; Ho Pan Sham; Bruce A Vallance; José L Puente; Eric C Martens; Gabriel Núñez
Journal:  Science       Date:  2012-05-10       Impact factor: 47.728

7.  Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens.

Authors:  Yan Zheng; Patricia A Valdez; Dimitry M Danilenko; Yan Hu; Susan M Sa; Qian Gong; Alexander R Abbas; Zora Modrusan; Nico Ghilardi; Frederic J de Sauvage; Wenjun Ouyang
Journal:  Nat Med       Date:  2008-02-10       Impact factor: 53.440

Review 8.  Pathogenic Escherichia coli.

Authors:  James B Kaper; James P Nataro; Harry L Mobley
Journal:  Nat Rev Microbiol       Date:  2004-02       Impact factor: 60.633

9.  Citrobacter rodentium is an unstable pathogen showing evidence of significant genomic flux.

Authors:  Nicola K Petty; Theresa Feltwell; Derek Pickard; Simon Clare; Ana L Toribio; Maria Fookes; Kevin Roberts; Rita Monson; Satheesh Nair; Robert A Kingsley; Richard Bulgin; Siouxsie Wiles; David Goulding; Thomas Keane; Craig Corton; Nicola Lennard; David Harris; David Willey; Richard Rance; Lu Yu; Jyoti S Choudhary; Carol Churcher; Michael A Quail; Julian Parkhill; Gad Frankel; Gordon Dougan; George P C Salmond; Nicholas R Thomson
Journal:  PLoS Pathog       Date:  2011-04-07       Impact factor: 6.823

10.  The cost of virulence: retarded growth of Salmonella Typhimurium cells expressing type III secretion system 1.

Authors:  Alexander Sturm; Matthias Heinemann; Markus Arnoldini; Arndt Benecke; Martin Ackermann; Matthias Benz; Jasmine Dormann; Wolf-Dietrich Hardt
Journal:  PLoS Pathog       Date:  2011-07-28       Impact factor: 6.823

View more
  59 in total

1.  Mucosal Barrier Depletion and Loss of Bacterial Diversity are Primary Abnormalities in Paediatric Ulcerative Colitis.

Authors:  Misagh Alipour; Deenaz Zaidi; Rosica Valcheva; Juan Jovel; Inés Martínez; Consolato Sergi; Jens Walter; Andrew L Mason; Gane Ka-Shu Wong; Levinus A Dieleman; Matthew W Carroll; Hien Q Huynh; Eytan Wine
Journal:  J Crohns Colitis       Date:  2015-12-09       Impact factor: 9.071

2.  Akkermansia muciniphila induces intestinal adaptive immune responses during homeostasis.

Authors:  Eduard Ansaldo; Leianna C Slayden; Krystal L Ching; Meghan A Koch; Natalie K Wolf; Damian R Plichta; Eric M Brown; Daniel B Graham; Ramnik J Xavier; James J Moon; Gregory M Barton
Journal:  Science       Date:  2019-06-21       Impact factor: 47.728

Review 3.  Citrobacter rodentium: a model enteropathogen for understanding the interplay of innate and adaptive components of type 3 immunity.

Authors:  D J Silberger; C L Zindl; C T Weaver
Journal:  Mucosal Immunol       Date:  2017-06-14       Impact factor: 7.313

4.  Virulence factors enhance Citrobacter rodentium expansion through aerobic respiration.

Authors:  Christopher A Lopez; Brittany M Miller; Fabian Rivera-Chávez; Eric M Velazquez; Mariana X Byndloss; Alfredo Chávez-Arroyo; Kristen L Lokken; Renée M Tsolis; Sebastian E Winter; Andreas J Bäumler
Journal:  Science       Date:  2016-09-15       Impact factor: 47.728

5.  Host response: Sifting out virulent bacteria.

Authors:  Naomi Attar
Journal:  Nat Rev Microbiol       Date:  2015-06       Impact factor: 60.633

6.  Neutrophils Restrict Tumor-Associated Microbiota to Reduce Growth and Invasion of Colon Tumors in Mice.

Authors:  Daniel Triner; Samantha N Devenport; Sadeesh K Ramakrishnan; Xiaoya Ma; Ryan A Frieler; Joel K Greenson; Naohiro Inohara; Gabriel Nunez; Justin A Colacino; Richard M Mortensen; Yatrik M Shah
Journal:  Gastroenterology       Date:  2018-12-11       Impact factor: 22.682

7.  Immunization of mice with chimeric antigens displaying selected epitopes confers protection against intestinal colonization and renal damage caused by Shiga toxin-producing Escherichia coli.

Authors:  David A Montero; Felipe Del Canto; Juan C Salazar; Sandra Céspedes; Leandro Cádiz; Mauricio Arenas-Salinas; José Reyes; Ángel Oñate; Roberto M Vidal
Journal:  NPJ Vaccines       Date:  2020-03-12       Impact factor: 7.344

8.  Antibodies Damage the Resilience of Fimbriae, Causing Them To Be Stiff and Tangled.

Authors:  Bhupender Singh; Narges Mortezaei; Stephen J Savarino; Bernt Eric Uhlin; Esther Bullitt; Magnus Andersson
Journal:  J Bacteriol       Date:  2016-12-13       Impact factor: 3.490

9.  Origins of the current seventh cholera pandemic.

Authors:  Dalong Hu; Bin Liu; Lu Feng; Peng Ding; Xi Guo; Min Wang; Boyang Cao; Peter R Reeves; Lei Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-14       Impact factor: 11.205

Review 10.  Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease.

Authors:  Joseph M Pickard; Melody Y Zeng; Roberta Caruso; Gabriel Núñez
Journal:  Immunol Rev       Date:  2017-09       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.